Maternal Vaccination During Pregnancy: Current Recommendations

Vaccination during pregnancy is a central part of preventive perinatal care. It protects the pregnant patient from infections that can become severe during pregnancy while transferring antibodies across the placenta to the fetus. This passive immunity can help shield newborns during the first weeks or months of life, before routine infant immunizations are fully established.

Recommendations differ according to the vaccine, gestational age, disease activity, season, maternal health, and national policy. Guidance from organizations such as the CDC, ACOG, WHO, and national immunization programs generally supports several vaccines during pregnancy, while live vaccines are usually postponed until after delivery.

The practical goal is to assess immunization status early, explain benefits and possible reactions clearly, and use shared decision-making when recommendations depend on local epidemiology. A prenatal vaccination plan should also account for travel, occupational exposure, household contacts, and conditions such as diabetes, asthma, or immune suppression.

Why Immunization Matters Before Birth

Pregnancy changes the immune, respiratory, and cardiovascular systems. As a result, infections such as influenza, COVID-19, and pertussis may cause more serious illness, hospitalization, premature birth, or other complications. Vaccination reduces the likelihood of severe disease and may lessen the risk that an infection disrupts antenatal care.

The fetus and newborn benefit through transplacental antibody transfer. Maternal IgG antibodies become especially important late in pregnancy, although the timing and strength of protection vary by vaccine and by the interval between vaccination and birth. Immunization does not guarantee that an infant will avoid infection, but it can reduce the severity of early-life disease.

Maternal vaccination also supports family and community protection. When pregnant patients, partners, grandparents, and caregivers are immunized where appropriate, newborns are less likely to encounter infectious diseases during a vulnerable period. This cocooning approach is particularly useful for pertussis, influenza, and respiratory viruses.

Vaccines Routinely Recommended During Pregnancy

Seasonal inactivated influenza vaccination is recommended during any trimester when influenza viruses are circulating. Pregnancy increases the risk of complications from influenza, and vaccination also provides antibodies that may protect the infant after birth. The injectable inactivated vaccine is used; live attenuated influenza vaccine delivered as a nasal spray is not recommended during pregnancy.

Tetanus, diphtheria, and acellular pertussis vaccination, commonly called Tdap, is recommended during every pregnancy, usually between 27 and 36 weeks. Many experts favor giving it earlier within that window to allow antibody development before delivery. Repeating Tdap in each pregnancy is advised even when the patient received it recently, because the aim is to maximize antibody transfer to each newborn.

COVID-19 vaccination is recommended for pregnant patients under current national schedules, including updated formulations when available. It can be administered during any trimester, and vaccination should not generally be delayed until after delivery. Pregnancy is associated with a higher risk of severe COVID-19, intensive care admission, and some adverse pregnancy outcomes, while available evidence has not shown that recommended COVID-19 vaccines cause infertility or increase miscarriage risk.

Some countries now offer maternal respiratory syncytial virus vaccination during a defined late-pregnancy window. In the United States, the Pfizer RSV vaccine, Abrysvo, is generally offered at 32 weeks 0 days through 36 weeks 6 days during seasonal administration. The purpose is to provide antibodies that help protect the infant against severe RSV disease. Local schedules may instead rely on an infant monoclonal antibody, so coordination between obstetric and pediatric teams is important.

Vaccines That Need Individual Assessment

Hepatitis B vaccination can be given during pregnancy when a patient is unvaccinated, incompletely vaccinated, or at risk of infection. Risk factors include a sexual partner with hepatitis B, multiple sexual partners, injection drug use, occupational exposure, or evaluation for a sexually transmitted infection. Testing for hepatitis B surface antigen is also a standard element of prenatal care, and newborns exposed to hepatitis B require timely prophylaxis after birth.

Hepatitis A, meningococcal, and polio vaccines are usually considered when the risk of infection is significant. Examples include international travel to areas with active transmission, an outbreak, occupational exposure, or a medical condition that increases the consequences of infection. Rabies post-exposure prophylaxis should not be withheld because of pregnancy; the danger of untreated rabies is far greater than the theoretical concern associated with vaccination.

Travel planning deserves particular attention. A pregnant patient may need protection against diseases circulating at a destination, yet some travel vaccines are avoided unless the benefit clearly outweighs the risk. Decisions should be made with a travel medicine or infectious disease specialist well before departure, especially when yellow fever vaccination, malaria exposure, or limited medical access is involved.

Vaccination after delivery remains valuable. If a patient lacks immunity to rubella or varicella, the relevant live vaccine is generally given postpartum rather than during pregnancy. Breastfeeding is usually compatible with routine maternal immunization, and postpartum vaccination can protect the parent and reduce household transmission without requiring separation from the infant.

Live Vaccines And Safety Counseling

Live attenuated vaccines, including measles-mumps-rubella and varicella vaccines, are generally contraindicated during pregnancy because they contain weakened forms of the relevant virus. Patients who are found to be nonimmune should usually receive these vaccines after delivery. They should also receive appropriate counseling about future pregnancy timing based on current national guidance.

An inadvertent live vaccine dose given shortly before pregnancy or during pregnancy is not generally a reason to recommend termination. The patient should be referred for appropriate counseling and documentation, but available surveillance data do not support a major fetal risk from accidental exposure to MMR or varicella vaccine.

Safety discussions should distinguish expected reactions from warning signs. Soreness, fatigue, headache, or a low-grade fever may occur after vaccination and usually resolve quickly. Severe allergic reactions are rare. A history of anaphylaxis to a vaccine component is a major contraindication, while many other conditions, including mild illness or breastfeeding, do not require postponement.

Patients often worry that vaccination could cause developmental problems, infertility, miscarriage, or infection in the fetus. Clear explanations should rely on surveillance systems, pregnancy registries, and large observational studies rather than dismissing concerns. The risks of the infection itself should be compared with the known safety profile of the recommended vaccine.

Timing, Documentation, And Coordination

The first prenatal assessment is an opportunity to review the vaccination record, previous infections, allergies, occupation, travel, and household exposures. Electronic immunization registries can help identify missing doses, but records may be incomplete across borders. When documentation is unavailable, clinicians should follow national guidance on serologic testing or revaccination rather than making assumptions.

Timing is especially important for vaccines intended to protect the newborn. Tdap and maternal RSV vaccination must be given early enough for antibody production and placental transfer. If delivery occurs soon after vaccination, the infant may receive less passive protection, but the dose may still protect the mother and contribute to family protection.

Coordination between obstetric, midwifery, primary care, pharmacy, and pediatric services reduces missed opportunities. The newborn team should know whether Tdap, influenza, COVID-19, or RSV vaccination was given and when. This information helps determine whether additional infant prevention, such as an RSV monoclonal antibody, is indicated under the local program.

The pandemic demonstrated how quickly perinatal services can adapt when travel, access, and infection-control conditions change. Lessons from telemedicine in perinatal care include the value of remote counseling, electronic records, and telephone follow-up. Telehealth cannot replace every examination or vaccination appointment, but it can help identify needs and direct patients to accessible immunization services.

Special Considerations In Perinatal Practice

Patients with high-risk pregnancies may need more urgent vaccination planning. Asthma, obesity, diabetes, cardiac disease, chronic lung disease, and immune compromise can increase the consequences of influenza or COVID-19. Immunosuppressive medication may affect vaccine response and requires individualized advice, particularly when live vaccines are being considered after delivery.

Placental health and maternal infection are closely connected. Vaccination prevents some infections before they can produce systemic inflammation, placental injury, fetal growth concerns, or preterm birth. Research into infection and placental findings, including the role of placental pathology, has reinforced the importance of preventing severe maternal viral disease and monitoring affected pregnancies carefully.

Equity also affects vaccine uptake. Cost, transportation, language barriers, immigration concerns, misinformation, and limited appointment availability can all delay immunization. Offering vaccination in prenatal clinics, pharmacies, and community settings can improve access. Written information in the patient’s preferred language and a respectful discussion of concerns are often as important as the clinical recommendation itself.

A strong recommendation should be specific: name the vaccine, explain why it is advised, state when it should be given, and document the plan. If a patient declines, the conversation should remain open at later visits. Repeated, respectful counseling is more effective than pressure and allows new evidence or changing circumstances to be addressed.

A Practical Prenatal Vaccination Checklist

• Review the immunization record at the first prenatal visit and update it after every dose.
• Offer seasonal inactivated influenza vaccination and the current COVID-19 vaccine according to national guidance.
• Schedule Tdap during the recommended late-pregnancy window in every pregnancy.
• Assess eligibility for maternal RSV vaccination and coordinate it with the infant prevention plan.
• Identify travel, occupational, household, medical, and exposure risks that may require hepatitis, rabies, or other individualized vaccination.

Effective maternal immunization depends on timely counseling and reliable follow-through. Obstetric services can integrate vaccine review into routine prenatal templates, use reminder systems, and provide same-day administration whenever possible. Pediatric teams should reinforce the plan during newborn care and ensure that postpartum vaccines are not overlooked.

Clinicians and public health professionals can use current national schedules, pregnancy safety surveillance, and specialist consultation to keep recommendations accurate as products and epidemiology change. Patients benefit when advice is consistent across every point of care, from the prenatal clinic to the delivery unit and postpartum visit. Use each antenatal encounter to assess protection, address concerns, and arrange the next appropriate vaccine.